Breaking Mental Health Barriers

Teva is working to shift the stigma around mental health. Listen as Eric Hughes, Executive Vice President of Global R&D and Chief Medical Officer, and Sven Dethlefs, Executive Vice President, North America Commercial share their perspectives and plans in this Mental Health Moment.

View the video transcript

There is a mental health crisis unfolding across the United States.

In fact, nearly 44 million adults in the United States experience mental illness each year.

And yet, stigma around openly discussing mental health and seeking treatment still exists.

This is an enormous challenge and one we can’t tackle alone.

 

It will take collaboration and effort from across the public, non-profit and private sectors

to address stigma around mental illness, elevate discussion on this topic

and ensure patients have access to the medicines and support they need.

 

At Teva, we are committed to making a difference thanks to the breadth of our available medicines,

our deep scientific and R&D expertise, our commitment to improving access to medicines,

and our unwavering dedication to patients.

 

Many within Teva, and especially our R&D team, work tirelessly every day to address unmet patient needs

and ensure we're tackling some of the country's most pressing health challenges, including mental health.

We are focused on developing medicines that help physicians better treat complex conditions

like those associated with mental health and helping patients feel uplifted and heard throughout their health journey.

 

Thank you for joining us for this mental health moment.

And we're just getting started.

We hope you'll join us.


At Teva, we are working to help reduce stigma around mental health by collaborating across the public, non-profit and private sectors to help patients feel cared for and heard throughout their mental health journey.

“Our team is working every day to address unmet patient needs and ensure we’re tackling the country’s most pressing mental health challenges.”


Find out more:

Share this article: